Page last updated: 2024-12-07

1,3,4-thiadiazole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,3,4-Thiadiazole is a heterocyclic compound with a five-membered ring containing two nitrogen atoms and one sulfur atom. It has been studied for its diverse biological activities, including antifungal, antibacterial, antiviral, anti-inflammatory, and anticancer properties. The synthesis of 1,3,4-thiadiazole derivatives often involves reactions like cyclization of thioamides or condensation of hydrazines with carboxylic acids. Its importance lies in its ability to serve as a scaffold for developing new pharmaceuticals and agrochemicals. The presence of the thiadiazole ring imparts unique properties to the molecule, allowing for various modifications and the development of compounds with specific biological targets.'

1,3,4-thiadiazole: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID119391
CHEBI ID39472
MeSH IDM0164178

Synonyms (14)

Synonym
thiadiazole
1,3,4-thiadiazole
CHEBI:39472
289-06-5
AKOS006277879
MBIZXFATKUQOOA-UHFFFAOYSA-N
[1,3,4]thiadiazole
unii-14iac3gh7g
14iac3gh7g ,
thiadiazole, 1,3,4-
DTXSID00183089
Q27120327
EN300-93326
Z1198156558

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" Thus, there is unmet medical need to develop safe drugs for the treatment of epilepsy with lower side effects and improved bioavailability profiles."( Molecular docking study, green synthesis and pharmacological evaluation of 1,3,4-thiadiazole derivatives as potential antiepileptic agents.
Brahmkshatriya, PS; Dinda, SC; Panda, JR; Ravi Kumar, BV; Sahoo, BM, 2013
)
0.62
" Besides, ADME results indicated that all compounds were potential orally bioavailable drug-like molecules."(
Altıntop, MD; Kucukoglu, K; Nadaroglu, H; Sever, B, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
" The preliminary bioassay showed that most of the compounds had better antibacterial activity than the parent compounds, 1,3,4-thia(oxa)diazoles, at the dosage 50μg/mL toward five test bacteria."( Synthesis of novel nalidixic acid-based 1,3,4-thiadiazole and 1,3,4-oxadiazole derivatives as potent antibacterial agents.
Aggarwal, N; Dureja, P; Khurana, JM; Kumar, R, 2012
)
0.65
" The input data are included adsorbent dosage (g), contact time (min) and pollutant concentration (mg/l)."( Adaptive neuro-fuzzy inference system model for adsorption of 1,3,4-thiadiazole-2,5-dithiol onto gold nanoparticales-activated carbon.
Ghaedi, AM; Ghaedi, M; Hosaininia, R; Taghizadeh, F; Vafaei, A, 2014
)
0.64
" Time-course and dose-response effects revealed that 5-butyl-2-(2,4-dihydroxyphenyl)-1,3,4-thiadiazole produced its maximum anticonvulsant action at 15 min after its ip administration to mice."( Characterization and preliminary anticonvulsant assessment of some 1,3,4-thiadiazole derivatives.
Karpińska, M; Luszczki, JJ; Matysiak, J; Niewiadomy, A, 2015
)
0.88
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
thiadiazole
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (228)

TimeframeStudies, This Drug (%)All Drugs %
pre-199017 (7.46)18.7374
1990's1 (0.44)18.2507
2000's12 (5.26)29.6817
2010's133 (58.33)24.3611
2020's65 (28.51)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 38.07

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index38.07 (24.57)
Research Supply Index5.44 (2.92)
Research Growth Index6.29 (4.65)
Search Engine Demand Index51.85 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (38.07)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews8 (3.48%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other222 (96.52%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]